Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
Clinical trial NCT02669173 · COMPLETED
Trial details
- NCT number
- NCT02669173
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-11
- Primary completion
- 2025-01-07
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.